Skip to main content

4 Result(s)

within J. Brüggen Remove this filter Immunology Remove this filter

and

  1. No Access

    Article

    Selective toxicity of neocarzinostatin-monoclonal antibody conjugates to the antigen-bearing human melanoma cell line in vitro

    Monoclonal antibodies (IgG1) against high molecular weight antigen A-1-43 on human melanoma cell line A-375 were successfully linked to the anti-tumour protein neocarzinostatin (NCS) using the heterobifunctional ...

    G. Lüders, W. Köhnlein, C. Sorg, J. Brüggen in Cancer Immunology, Immunotherapy (1985)

  2. No Access

    Article

    Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies

    The hybridoma technique was used to generate monoclonal antibodies against a wide spectrum of melanoma-associated surface antigens. Mice were immunized against the human melanoma lines Mel A-375, SK Mel-25, an...

    J. Brüggen, C. Sorg in Cancer Immunology, Immunotherapy (1983)

  3. No Access

    Article

    Membrane associated antigens of human malignant melanoma V: Serological ty** of cell lines using antisera from nonhuman primates

    Antisera against various melanoma cell lines were raised in nonhuman primates (Cercopithecus aethiop.). After exhaustive absorption with AB Rh + red blood cells and pooled platelets from about 200 donors the sera...

    J. Brüggen, C. Sorg, E. Macher in Cancer Immunology, Immunotherapy (1978)

  4. No Access

    Article

    Membrane-associated antigens of human malignant melanoma IV: Changes in expression of antigens on cultured melanoma cells

    Established melanoma cell lines were cultured for one passage (approximately 1 week) in different lots of fetal calf and new born calf sera and then tested against a panel of previously positively reacting ser...

    C. Sorg, J. Brüggen, Edelgard Seibert, E. Macher in Cancer Immunology, Immunotherapy (1978)